103 related articles for article (PubMed ID: 8757101)
1. [HIV infection es IgA nephropathy].
Nagy Z; Uj M; Orbán D; Csima A; Szücs G; Nagy J
Orv Hetil; 1996 Jun; 137(22):1197-8. PubMed ID: 8757101
[TBL] [Abstract][Full Text] [Related]
2. IgA nephritis in HIV-positive patients: a new HIV-associated nephropathy?
Katz A; Bargman JM; Miller DC; Guo JW; Ghali VS; Schoeneman MJ
Clin Nephrol; 1992 Aug; 38(2):61-8. PubMed ID: 1516281
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
[TBL] [Abstract][Full Text] [Related]
4. Spread of HIV in one village in central China with a high prevalence rate of blood-borne AIDS.
Zhang W; Hu D; Xi Y; Zhang M; Duan G
Int J Infect Dis; 2006 Nov; 10(6):475-80. PubMed ID: 17049292
[TBL] [Abstract][Full Text] [Related]
5. Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.
Marcelino JM; Nilsson C; Barroso H; Gomes P; Borrego P; Maltez F; Rosado L; Doroana M; Antunes F; Taveira N
AIDS; 2008 Nov; 22(17):2257-65. PubMed ID: 18981765
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated IgA nephropathy--a post-mortem study.
Beaufils H; Jouanneau C; Katlama C; Sazdovitch V; Hauw JJ
Nephrol Dial Transplant; 1995; 10(1):35-8. PubMed ID: 7724026
[TBL] [Abstract][Full Text] [Related]
7. Virological exploration of individuals with discordant HIV screening tests.
Pasquier C; Sandres-Sauné K; Mansuy JM; Puissant B; Viraben R; Spenato N; Miédougé M; Massip P; Blancher A; Izopet J
J Clin Virol; 2004 Jul; 30(3):218-23. PubMed ID: 15135738
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M
J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
Margalith M; Levy E; Rinaldo CR; Detels R; Phair J; Kaslow R; Saah AJ; Sarov B
J Hum Virol; 2001; 4(5):269-77. PubMed ID: 11907384
[TBL] [Abstract][Full Text] [Related]
10. A new combined HIV p24 antigen and anti-HIV-1/2/O screening assay.
Polywka S; Duttmann H; Lübben F; Laufs R; Feldner J
Methods Mol Biol; 2005; 304():229-43. PubMed ID: 16061980
[TBL] [Abstract][Full Text] [Related]
11. [The risk of seroconversion in surgeons of the hepatitis B, hepatitis C and human immunodeficiency viruses (in a specific surgical population)].
Mineiro J; Catela A; Pedro M; Gouveia A; Gomes AR
Acta Med Port; 1997; 10(6-7):455-61. PubMed ID: 9341037
[TBL] [Abstract][Full Text] [Related]
12. Maintenance hemodialysis in patients with HIV-associated nephropathy.
Dave MB; Shabih K; Blum S
Clin Nephrol; 1998 Dec; 50(6):367-74. PubMed ID: 9877110
[TBL] [Abstract][Full Text] [Related]
13. False-negative HIV antibody test results.
Preiser W; Brink NS; Hayman A; Waite J; Balfe P; Tedder RS
J Med Virol; 2000 Jan; 60(1):43-7. PubMed ID: 10568762
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 and HIV-2 antibodies in Nigerian populations with high- and low-risk behaviour patterns.
Williams EE; Mohammed I; Chikwem JO; Akinsete R; Udofia O; Schulze G; Fleming AF; Hunsmann G
AIDS; 1990 Oct; 4(10):1041-2. PubMed ID: 2261124
[No Abstract] [Full Text] [Related]
15. HIV antibody responses in children of HIV-infected mothers.
Sever JL; Rakusan TA; Campos JM; O'Donnell RM; Price VA
Pediatr AIDS HIV Infect; 1996 Aug; 7(4):246-53. PubMed ID: 11361717
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Murex HIV Ag/Ab Combination assay when used with dried blood spots.
Lakshmi V; Sudha T; Bhanurekha M; Dandona L
Clin Microbiol Infect; 2007 Nov; 13(11):1134-6. PubMed ID: 17725648
[TBL] [Abstract][Full Text] [Related]
17. [Four year management of HIV serology at the National Center of Blood Transfusion in Conakry].
Loua A; Magassouba FB; Camara M; Haba NG; Balde AM
Bull Soc Pathol Exot; 2004 May; 97(2):139-41. PubMed ID: 15255362
[TBL] [Abstract][Full Text] [Related]
18. High-risk status of HIV-1 infection in the very low epidemic country, Mongolia, 2007.
Davaalkham J; Unenchimeg P; Baigalmaa Ch; Oyunbileg B; Tsuchiya K; Hachiya A; Gatanaga H; Nyamkhuu D; Oka S
Int J STD AIDS; 2009 Jun; 20(6):391-4. PubMed ID: 19451323
[TBL] [Abstract][Full Text] [Related]
19. Presence of HIV-1 neutralizing IgA antibodies in primary HIV-1 infected patients.
Söderlund J; Hirbod T; Goh LE; Andersson J; Broliden K
Scand J Infect Dis; 2004; 36(9):663-9. PubMed ID: 15370653
[TBL] [Abstract][Full Text] [Related]
20. [Establishment and evaluation of the diagnostic kit for anti-HIV1/2 antibody and P24 antigen].
Hu Y; Hou J; Feng YQ; Feng CF; Shi SJ; Shen HH; Wang ZJ; Wang BJ; Mao PY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):391-3. PubMed ID: 18322614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
